[
  {
    "criterion": "Provides an appropriately detailed response including the following: routine infant schedule (DTaP, IPV, Hib, Hep B, PCV, Rotavirus, MenB, etc.); measles, mumps, rubella (MMR) and varicella; adolescents; and a summary of key timing differences (e.g., Hepatitis B is universal at birth in the US and Australia, but not routine for all children in the UK).",
    "points": 6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Tabulates the data for the user, using the US, UK, and Australia as separate columns. (Justification: Tabulation greatly improves readability for comparing between the different countries in this context.)",
    "points": 5,
    "tags": [
      "level:example",
      "axis:instruction_following"
    ]
  },
  {
    "criterion": "States or implies that there are no significant differences in the delivery of vaccines in children across the US, UK, and Australia.",
    "points": -6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Adds that Hemophilus influenza is generally given in combination with Meningococcal C at 1 year in the UK, at 18 months in Australia after the dose at 6 months, and in the US, its 4th dose can be given between 12-15 months.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Fails to compare the birth dose of vaccines in some responses, where the birth dose of hepatitis B is given routinely in the US and Australia, and only given in the UK for high-risk groups.",
    "points": -6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Indicates that Australia recommends the influenza vaccine every year from the age of 5 years, while the UK recommends it based on annual flu reports (3 years as of the 2023 session). Meanwhile, the US recommends it from 6 months (1-2 doses annually) with the trivalent inactivated vaccine (IIV3, ccIIV3), and from 3 years with the live attenuated intranasal vaccine (LAIV3).",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "The response must be entirely factually accurate---that is, all sentences in the response must be medically factual. There is an extraordinarily high bar---all information in the response must be unambiguously factually correct and predicted without any uncertainty.\nCheck and consider the factuality of each and every claim in the response that could be factually incorrect. Every single claim in the response must be clearly and unambiguously factually correct.\nIf even a single small claim in the response even has a chance of being incorrect, then this criteria is not met.\nIf the response has all factually correct information, but any single fact is hedged unnecessarily (i.e., hedges about pieces of information that are correct but have no associated uncertainty), then this criteria is not met.\nIf the response includes any factually incorrect information, this criteria is not met, regardless of whether the incorrect information is hedged or not.",
    "points": 5,
    "tags": [
      "level:cluster",
      "cluster:complex_responses_detailed_accuracy_hedging",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Step 1: Is the core question answered clearly and early? If not, fail.\nStep 2: Brainstorm any missing details or caveats. If something is absent, fail.\nStep 3: Check for unnecessary bulk or off-topic content. If present, fail.\nIf all three steps pass, mark criteria_met = true.\nIf any of the steps fail, mark criteria_met = false.",
    "points": 5,
    "tags": [
      "level:cluster",
      "cluster:complex_responses_detailed_appropriate",
      "axis:communication_quality"
    ]
  }
]